Yuki Gosei Kogyo Co., Ltd. (TYO:4531)

Japan · Delayed Price · Currency is JPY

344.00

-11.00 (-3.10%)

Jul 24, 2026, 3:30 PM JST

30.80% (1Y)

Market Cap	7.41B +30.8%
Revenue (ttm)	15.45B +2.1%
Net Income	313.00M -65.1%
EPS	14.50 -65.0%
Shares Out	21.54M
PE Ratio	23.73
Forward PE	n/a
Dividend	10.00 (2.91%)
Ex-Dividend Date	Mar 30, 2026

Volume	85,600
Open	353.00
Previous Close	355.00
Day's Range	342.00 - 353.00
52-Week Range	261.00 - 640.00
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Yuki Gosei Kogyo

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, nicotinamide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufactur... [Read more]

Industry Chemicals

Sector Materials

Founded 1947

Employees 296

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4531

Full Company Profile

Financial Performance

In fiscal year 2026, Yuki Gosei Kogyo's revenue was 15.45 billion, an increase of 2.12% compared to the previous year's 15.13 billion. Earnings were 313.00 million, a decrease of -65.07%.

Financial Statements